Lannett Company Inc
Change company Symbol lookup
Select an option...
LCI Lannett Company Inc
TDBZX AB Multi-Manager Select 2010 Fund Class Z
TDBYX AB Multi-Manager Select 2010 Fund Advisor Class
TDBRX AB Multi-Manager Select 2010 Fund Class R
TDBKX AB Multi-Manager Select 2010 Fund Class K
TDBCX AB Multi-Manager Select 2010 Fund Class C
TDAPX AB Multi-Manager Select 2055 Fund Class A
TDAGX AB Multi-Manager Select 2025 Fund Class A
ASFQX 361 U.S. Small Cap Equity Fund Investor Class
AMFQX 361 Managed Futures Strategy Fund Investor Class
Go

Health Care : Pharmaceuticals | Small Cap ValueCompany profile

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.

Closing Price
$5.68
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
681,433
0

Activision Blizzard stock falls as 'Destiny' rights ceded to Bungie

4:28 pm ET January 10, 2019 (MarketWatch)
Print

Activision Blizzard Inc. (ATVI) shares fell in the extended session Thursday as the videogame publisher said it was ceding rights to the "Destiny" franchise to Bungie Inc. Activision shares dropped 6.7% after hours, following a 1% gain to close at $51.35 in the regular session. In a filing with the Securities and Exchange Commission, Activision said Bungie would assume "full publishing rights and responsibilities for the 'Destiny' franchise" and "will own and develop the franchise." Activision said it does not expect "material revenue, operating income or operating loss" from "Destiny" in 2019.

-Wallace Witkowski; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

January 10, 2019 16:28 ET (21:28 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.